Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
28 | 3 | NUTRITION & DIETETICS//OBESITY//PHYSICAL ACTIVITY | 115300 |
782 | 2 | OBESITY//SIBUTRAMINE//WEIGHT LOSS | 12519 |
6118 | 1 | SIBUTRAMINE//ORLISTAT//LORCASERIN | 1557 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | SIBUTRAMINE | authKW | 3589545 | 17% | 66% | 269 |
2 | ORLISTAT | authKW | 1950666 | 13% | 48% | 200 |
3 | LORCASERIN | authKW | 446133 | 3% | 57% | 39 |
4 | PHENTERMINE | authKW | 419837 | 3% | 45% | 46 |
5 | ANTI OBESITY DRUGS | authKW | 414701 | 3% | 41% | 50 |
6 | DEXFENFLURAMINE | authKW | 328509 | 3% | 32% | 50 |
7 | ANTI OBESITY AGENTS | authKW | 254028 | 2% | 43% | 29 |
8 | CONTRAVE | authKW | 143929 | 1% | 89% | 8 |
9 | SIBUTRAMINE HYDROCHLORIDE | authKW | 129535 | 1% | 80% | 8 |
10 | PHENTERMINE TOPIRAMATE | authKW | 110194 | 0% | 78% | 7 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 11093 | 33% | 0% | 510 |
2 | Nutrition & Dietetics | 10496 | 22% | 0% | 343 |
3 | Pharmacology & Pharmacy | 2733 | 26% | 0% | 403 |
4 | Medicine, General & Internal | 1690 | 16% | 0% | 255 |
5 | Primary Health Care | 492 | 2% | 0% | 29 |
6 | Toxicology | 107 | 3% | 0% | 51 |
7 | Cardiac & Cardiovascular System | 66 | 4% | 0% | 61 |
8 | Psychiatry | 44 | 3% | 0% | 48 |
9 | Peripheral Vascular Diseases | 35 | 2% | 0% | 34 |
10 | Behavioral Sciences | 17 | 1% | 0% | 19 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | OBES CLIN TRIALS PROGRAM | 91078 | 0% | 75% | 6 |
2 | COMPREHENS WEIGHT CONTROL | 60715 | 0% | 50% | 6 |
3 | COMPREHENS WEIGHT CONTROL PROGRAM | 52190 | 0% | 37% | 7 |
4 | ENDOCRINOL OBES EATING DISORDERS GRP | 45539 | 0% | 75% | 3 |
5 | G DESCOVICH ATHEROSCLEROSIS STUDY | 34475 | 1% | 15% | 11 |
6 | OBES CLIN TRIALS PROGRAMME | 26020 | 0% | 43% | 3 |
7 | WEIGHT MANAGEMENT | 25283 | 1% | 13% | 10 |
8 | CARDIOVASC PREVENT OUTCOMES | 22071 | 0% | 18% | 6 |
9 | ANA BILIM DALI | 20240 | 0% | 100% | 1 |
10 | ARTIRMA HASTANESI | 20240 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF OBESITY | 54510 | 9% | 2% | 137 |
2 | OBESITY RESEARCH | 36049 | 3% | 3% | 52 |
3 | DIABETES OBESITY & METABOLISM | 11804 | 2% | 2% | 37 |
4 | OBESITY | 8448 | 3% | 1% | 42 |
5 | OBESITY REVIEWS | 3955 | 1% | 1% | 15 |
6 | OBESITY FACTS | 2672 | 1% | 2% | 8 |
7 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2269 | 2% | 0% | 26 |
8 | OBESITY AND METABOLISM-MILAN | 1892 | 0% | 3% | 3 |
9 | DIABETES CARE | 1746 | 2% | 0% | 32 |
10 | JOURNAL OF CLINICAL PHARMACOLOGY | 1582 | 1% | 0% | 21 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIBUTRAMINE | 3589545 | 17% | 66% | 269 | Search SIBUTRAMINE | Search SIBUTRAMINE |
2 | ORLISTAT | 1950666 | 13% | 48% | 200 | Search ORLISTAT | Search ORLISTAT |
3 | LORCASERIN | 446133 | 3% | 57% | 39 | Search LORCASERIN | Search LORCASERIN |
4 | PHENTERMINE | 419837 | 3% | 45% | 46 | Search PHENTERMINE | Search PHENTERMINE |
5 | ANTI OBESITY DRUGS | 414701 | 3% | 41% | 50 | Search ANTI+OBESITY+DRUGS | Search ANTI+OBESITY+DRUGS |
6 | DEXFENFLURAMINE | 328509 | 3% | 32% | 50 | Search DEXFENFLURAMINE | Search DEXFENFLURAMINE |
7 | ANTI OBESITY AGENTS | 254028 | 2% | 43% | 29 | Search ANTI+OBESITY+AGENTS | Search ANTI+OBESITY+AGENTS |
8 | CONTRAVE | 143929 | 1% | 89% | 8 | Search CONTRAVE | Search CONTRAVE |
9 | SIBUTRAMINE HYDROCHLORIDE | 129535 | 1% | 80% | 8 | Search SIBUTRAMINE+HYDROCHLORIDE | Search SIBUTRAMINE+HYDROCHLORIDE |
10 | PHENTERMINE TOPIRAMATE | 110194 | 0% | 78% | 7 | Search PHENTERMINE+TOPIRAMATE | Search PHENTERMINE+TOPIRAMATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |